Montelukast Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Montelukast Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Montelukast Drug market is segmented into
Tablets
Oral Granules
Segment by Application, the Montelukast Drug market is segmented into
Hospital
Drug Store
Others
Regional and Country-level Analysis
The Montelukast Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Montelukast Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Montelukast Drug Market Share Analysis
Montelukast Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Montelukast Drug business, the date to enter into the Montelukast Drug market, Montelukast Drug product introduction, recent developments, etc.
The major vendors covered:
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
1 Study Coverage
1.1 Montelukast Drug Product Introduction
1.2 Market Segments
1.3 Key Montelukast Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Montelukast Drug Market Size Growth Rate by Type
1.4.2 Tablets
1.4.3 Oral Granules
1.5 Market by Application
1.5.1 Global Montelukast Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drug Store
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Montelukast Drug Market Size, Estimates and Forecasts
2.1.1 Global Montelukast Drug Revenue 2015-2026
2.1.2 Global Montelukast Drug Sales 2015-2026
2.2 Global Montelukast Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Montelukast Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Montelukast Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Montelukast Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Montelukast Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Montelukast Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Montelukast Drug Revenue Forecast by Region (2021-2026)
3 Global Montelukast Drug Competitor Landscape by Players
3.1 Global Top Montelukast Drug Sales by Manufacturers
3.1.1 Global Montelukast Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Montelukast Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Montelukast Drug Manufacturers by Revenue
3.2.1 Global Montelukast Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Montelukast Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Montelukast Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Montelukast Drug Revenue in 2019
3.2.5 Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Montelukast Drug Price by Manufacturers
3.4 Global Montelukast Drug Manufacturing Base Distribution, Product Types
3.4.1 Montelukast Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Montelukast Drug Product Type
3.4.3 Date of International Manufacturers Enter into Montelukast Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Montelukast Drug Market Size by Type (2015-2020)
4.1.1 Global Montelukast Drug Sales by Type (2015-2020)
4.1.2 Global Montelukast Drug Revenue by Type (2015-2020)
4.1.3 Montelukast Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Montelukast Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Montelukast Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Montelukast Drug Revenue Forecast by Type (2021-2026)
4.2.3 Montelukast Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Montelukast Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Montelukast Drug Market Size by Application (2015-2020)
5.1.1 Global Montelukast Drug Sales by Application (2015-2020)
5.1.2 Global Montelukast Drug Revenue by Application (2015-2020)
5.1.3 Montelukast Drug Price by Application (2015-2020)
5.2 Montelukast Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Montelukast Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Montelukast Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Montelukast Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Montelukast Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Montelukast Drug Sales YoY Growth 2015-2026
6.1.2 Japan Montelukast Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Montelukast Drug Market Share in Global Market 2015-2026
6.2 Japan Montelukast Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Montelukast Drug Players by Sales (2015-2020)
6.2.2 Japan Top Montelukast Drug Players by Revenue (2015-2020)
6.3 Japan Montelukast Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Montelukast Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Montelukast Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Montelukast Drug Price by Type (2015-2020)
6.4 Japan Montelukast Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Montelukast Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Montelukast Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Montelukast Drug Price Forecast by Type (2021-2026)
6.5 Japan Montelukast Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Montelukast Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Montelukast Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Montelukast Drug Price by Application (2015-2020)
6.6 Japan Montelukast Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Montelukast Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Montelukast Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Montelukast Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Montelukast Drug Market Size YoY Growth 2015-2026
7.2 North America Montelukast Drug Market Facts & Figures by Country
7.2.1 North America Montelukast Drug Sales by Country (2015-2020)
7.2.2 North America Montelukast Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Montelukast Drug Market Size YoY Growth 2015-2026
8.2 Europe Montelukast Drug Market Facts & Figures by Country
8.2.1 Europe Montelukast Drug Sales by Country
8.2.2 Europe Montelukast Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Montelukast Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Montelukast Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Montelukast Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Montelukast Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Montelukast Drug Market Size YoY Growth 2015-2026
10.2 Latin America Montelukast Drug Market Facts & Figures by Country
10.2.1 Latin America Montelukast Drug Sales by Country
10.2.2 Latin America Montelukast Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Montelukast Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Montelukast Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Montelukast Drug Sales by Country
11.2.2 Middle East and Africa Montelukast Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck & Co.
12.1.1 Merck & Co. Corporation Information
12.1.2 Merck & Co. Description and Business Overview
12.1.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co. Montelukast Drug Products Offered
12.1.5 Merck & Co. Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Montelukast Drug Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Description and Business Overview
12.3.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Montelukast Drug Products Offered
12.3.5 Mylan Recent Development
12.4 Glenmark Pharmaceuticals
12.4.1 Glenmark Pharmaceuticals Corporation Information
12.4.2 Glenmark Pharmaceuticals Description and Business Overview
12.4.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Glenmark Pharmaceuticals Montelukast Drug Products Offered
12.4.5 Glenmark Pharmaceuticals Recent Development
12.5 Hikma Group
12.5.1 Hikma Group Corporation Information
12.5.2 Hikma Group Description and Business Overview
12.5.3 Hikma Group Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hikma Group Montelukast Drug Products Offered
12.5.5 Hikma Group Recent Development
12.6 Sandoz
12.6.1 Sandoz Corporation Information
12.6.2 Sandoz Description and Business Overview
12.6.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sandoz Montelukast Drug Products Offered
12.6.5 Sandoz Recent Development
12.7 Torrent Pharmaceuticals
12.7.1 Torrent Pharmaceuticals Corporation Information
12.7.2 Torrent Pharmaceuticals Description and Business Overview
12.7.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Torrent Pharmaceuticals Montelukast Drug Products Offered
12.7.5 Torrent Pharmaceuticals Recent Development
12.8 Lannett Company
12.8.1 Lannett Company Corporation Information
12.8.2 Lannett Company Description and Business Overview
12.8.3 Lannett Company Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lannett Company Montelukast Drug Products Offered
12.8.5 Lannett Company Recent Development
12.9 Apotex
12.9.1 Apotex Corporation Information
12.9.2 Apotex Description and Business Overview
12.9.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Apotex Montelukast Drug Products Offered
12.9.5 Apotex Recent Development
12.10 Dr. Reddys Laboratories
12.10.1 Dr. Reddys Laboratories Corporation Information
12.10.2 Dr. Reddys Laboratories Description and Business Overview
12.10.3 Dr. Reddys Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Dr. Reddys Laboratories Montelukast Drug Products Offered
12.10.5 Dr. Reddys Laboratories Recent Development
12.11 Merck & Co.
12.11.1 Merck & Co. Corporation Information
12.11.2 Merck & Co. Description and Business Overview
12.11.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck & Co. Montelukast Drug Products Offered
12.11.5 Merck & Co. Recent Development
12.12 Accord Healthcare
12.12.1 Accord Healthcare Corporation Information
12.12.2 Accord Healthcare Description and Business Overview
12.12.3 Accord Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Accord Healthcare Products Offered
12.12.5 Accord Healthcare Recent Development
12.13 Hetero
12.13.1 Hetero Corporation Information
12.13.2 Hetero Description and Business Overview
12.13.3 Hetero Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hetero Products Offered
12.13.5 Hetero Recent Development
12.14 Unimark
12.14.1 Unimark Corporation Information
12.14.2 Unimark Description and Business Overview
12.14.3 Unimark Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Unimark Products Offered
12.14.5 Unimark Recent Development
12.15 Ajanta Pharma
12.15.1 Ajanta Pharma Corporation Information
12.15.2 Ajanta Pharma Description and Business Overview
12.15.3 Ajanta Pharma Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Ajanta Pharma Products Offered
12.15.5 Ajanta Pharma Recent Development
12.16 MACLEODS
12.16.1 MACLEODS Corporation Information
12.16.2 MACLEODS Description and Business Overview
12.16.3 MACLEODS Sales, Revenue and Gross Margin (2015-2020)
12.16.4 MACLEODS Products Offered
12.16.5 MACLEODS Recent Development
12.17 Jubilant Pharma
12.17.1 Jubilant Pharma Corporation Information
12.17.2 Jubilant Pharma Description and Business Overview
12.17.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Jubilant Pharma Products Offered
12.17.5 Jubilant Pharma Recent Development
12.18 Unichem Laboratories
12.18.1 Unichem Laboratories Corporation Information
12.18.2 Unichem Laboratories Description and Business Overview
12.18.3 Unichem Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Unichem Laboratories Products Offered
12.18.5 Unichem Laboratories Recent Development
12.19 Amneal Pharmaceuticals
12.19.1 Amneal Pharmaceuticals Corporation Information
12.19.2 Amneal Pharmaceuticals Description and Business Overview
12.19.3 Amneal Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Amneal Pharmaceuticals Products Offered
12.19.5 Amneal Pharmaceuticals Recent Development
12.20 Shanghai Anbison Lab
12.20.1 Shanghai Anbison Lab Corporation Information
12.20.2 Shanghai Anbison Lab Description and Business Overview
12.20.3 Shanghai Anbison Lab Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Shanghai Anbison Lab Products Offered
12.20.5 Shanghai Anbison Lab Recent Development
12.21 Perrigo
12.21.1 Perrigo Corporation Information
12.21.2 Perrigo Description and Business Overview
12.21.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Perrigo Products Offered
12.21.5 Perrigo Recent Development
12.22 Cipla
12.22.1 Cipla Corporation Information
12.22.2 Cipla Description and Business Overview
12.22.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cipla Products Offered
12.22.5 Cipla Recent Development
12.23 CSPC Ouyi Pharmaceutical
12.23.1 CSPC Ouyi Pharmaceutical Corporation Information
12.23.2 CSPC Ouyi Pharmaceutical Description and Business Overview
12.23.3 CSPC Ouyi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.23.4 CSPC Ouyi Pharmaceutical Products Offered
12.23.5 CSPC Ouyi Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Montelukast Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Montelukast Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
*If Applicable.